Westlake Pharmaceuticals (Hangzhou) Co., Ltd.

Quick facts

Phase 3 pipeline

• WPV01 · Infectious Diseases
  WPV01 is a small molecule drug that targets the SARS-CoV-2 main protease.

Phase 1 pipeline

• [14C]-WPV01
• WPV01 Dose 1-4
• WPV01 Dose 13-15 and Ritonavir
• WPV01 Dose 5-8 and Ritonavir
• WPV01 Dose 9-12

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Westlake Pharmaceuticals (Hangzhou) Co., Ltd. portfolio CI brief
• Westlake Pharmaceuticals (Hangzhou) Co., Ltd. pipeline updates RSS